Xeomin
Payments companies reported to CMS as associated with Xeomin. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Xeomin, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Xeomin
These are the largest totals companies reported as associated with Xeomin. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Todd Stitik | Newark, NJ | Pain Medicine (Physical Medicine & Rehabilitation) | $121,819.61 |
| Gerard Francisco | Houston, TX | Physical Medicine & Rehabilitation | $118,227.54 |
| Monica Verduzco-Gutierrez | San Antonio, TX | Brain Injury Medicine (Physical Medicine & Rehabilitation) | $111,752.79 |
| Heather Walker | North Charleston, SC | Spinal Cord Injury Medicine | $108,923.28 |
| Ryan Hafner | Sarasota, FL | Physical Medicine & Rehabilitation | $78,860.05 |
| Daniel Belkin-Holland | New York, NY | Procedural Dermatology | $69,605.00 |
| Sheila Farhang | Oro Valley, AZ | Dermatology | $67,225.08 |
| Gideon Kwok | Rancho Cucamonga, CA | $63,216.58 | |
| Laxman Bahroo | Washington, DC | Neurology (Psychiatry & Neurology) | $63,002.89 |
| Warner Carr | Laguna Niguel, CA | Allergy | $52,980.21 |
Prescribed Xeomin?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.